Plenty of money in the bank, numerous INDs and trials with near term inflection points, a recent acquisition for a similar company with arguably an inferior product... Hard not to like cu6.
not to mention 2 prvs
Ann: IND approval from the FDA for theranostic SAR-Bombesin trial, page-4
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.04 |
Change
0.470(8.44%) |
Mkt cap ! $1.897B | |||
| Open | High | Low | Value | Volume |
| $5.68 | $6.17 | $5.68 | $12.71M | 2.121M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 9291 | $6.03 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.04 | 529 | 2 |
View Market Depth
| Last trade - 15.49pm 12/07/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |